Biopharma bites: Avalyn eyes $200M IPO, Pfizer cuts manufacturing staff, and more from Sun Pharma, Novartis

FierceBiotechBoehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset

Endpoints NewsBayer to make 'careful but aggressive' return to pharma M&A, CEO says

Endpoints NewsAlkermes' narcolepsy Phase 3 success; Boehringer's antibody deal

FierceBiotechAstraZeneca’s $800M bet undermined by immunogenicity in phase 3

10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After A Strong Year And Recent Share Price Pullback - Yahoo Finance

PharmaVoiceHow tough is it getting for vaccine makers in the U.S.?

FDA News ReleasesFDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA

Endpoints NewsKnit Health raises $11.6M for 'fundamentally different' approach to healthcare AI

BioWorldArchitect Therapeutics reports new CDK2 inhibitors

BioWorldZhongshan Institute for Drug Discovery synthesizes YAP1/TEAD interaction inhibitors

BioWorldFirst cruise ship hantavirus genome points to zoonotic spillover

BioWorldCuracle, Memento ink $1B deal for ocular TIE2/VEGF bispecific